Literature DB >> 20691174

Thyroid hormone testing by tandem mass spectrometry.

Offie P Soldin1, Steven J Soldin.   

Abstract

In the euthyroid person, absolute free thyroxine concentrations remain constant and correlate with the tissue hormone level, its biologic effect and the metabolic status of the patient. However, most circulating thyroid hormone is bound to plasma proteins and only a minute amount is in the unbound free form. Studies have shown that current free thyroxine immunoassays are binding protein dependent. Novel high-performance liquid chromatography tandem mass spectrometry (LC/MS/MS) methods have successfully dealt with problems inherent in many immunoassays for thyroid hormones and afforded improved specificity and accuracy in thyroid hormone measurements. We emphasize problems with thyroid hormone testing employing immunoassays including direct and indirect thyroid hormone immunoassays, sample processing, methods of free hormone separation and review the emerging role of liquid chromatography-tandem mass spectrometry in thyroid hormone testing. The latest generation of tandem mass spectrometers has superior limits of quantification, permitting omission of previously employed derivatization steps. Liquid chromatography-tandem mass spectrometry affords the specificity, precision, and limits of quantification necessary for the reliable measurement of thyroid hormones, enhancing diagnostic capabilities, and affording the profiles of the iodothyronines and thyronamines. These methods are especially important in states of disease and during pregnancy when protein binding is a factor that interferes with other methods for thyroid hormone analysis. Copyright Â
© 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691174      PMCID: PMC3634329          DOI: 10.1016/j.clinbiochem.2010.07.020

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  55 in total

1.  Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  L M Demers; C A Spencer
Journal:  Clin Endocrinol (Oxf)       Date:  2003-02       Impact factor: 3.478

Review 2.  Reference methods for the measurement of free thyroid hormones in blood: evaluation of potential reference methods for free thyroxine.

Authors:  Steen S Holm; Steen H Hansen; Jens Faber; Poul Staun-Olsen
Journal:  Clin Biochem       Date:  2004-02       Impact factor: 3.281

3.  Use of frozen sera for FT4 standardization: investigation by equilibrium dialysis combined with isotope dilution-mass spectrometry and immunoassay.

Authors:  Katleen Van Uytfanghe; Dietmar Stöckl; H Alec Ross; Linda M Thienpont
Journal:  Clin Chem       Date:  2006-07-13       Impact factor: 8.327

4.  Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum.

Authors:  Linda M Thienpont; Graham Beastall; Nicholas D Christofides; James D Faix; Tamio Ieiri; Véronique Jarrige; W Greg Miller; Richard Miller; Jerald C Nelson; Cathérine Ronin; H Alec Ross; Michael Rottmann; Jos H Thijssen; Brigitte Toussaint
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

5.  A major step forward in the routine measurement of serum free thyroid hormones.

Authors:  Linda M Thienpont
Journal:  Clin Chem       Date:  2008-04       Impact factor: 8.327

6.  Isotope dilution-liquid chromatography/electrospray ionization-tandem mass spectrometry for the determination of serum thyroxine as a potential reference method.

Authors:  V I De Brabandere; P Hou; D Stöckl; L M Thienpont; A P De Leenheer
Journal:  Rapid Commun Mass Spectrom       Date:  1998       Impact factor: 2.419

7.  Heterophilic antibodies remain a problem for the immunoassay laboratory.

Authors:  G Ward; L McKinnon; T Badrick; P E Hickman
Journal:  Am J Clin Pathol       Date:  1997-10       Impact factor: 2.493

Review 8.  Thyroidal complications of pregnancy.

Authors:  F Innerfield; C S Hollander
Journal:  Med Clin North Am       Date:  1977-01       Impact factor: 5.456

9.  Candidate reference method for total thyroxine in human serum: use of isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization.

Authors:  Susan S-C Tai; Lorna T Sniegoski; Michael J Welch
Journal:  Clin Chem       Date:  2002       Impact factor: 8.327

10.  Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations.

Authors:  Michèle d'Herbomez; Gérard Forzy; Françoise Gasser; Catherine Massart; Andrée Beaudonnet; Rèmy Sapin
Journal:  Clin Chem Lab Med       Date:  2003-07       Impact factor: 3.694

View more
  30 in total

1.  Is measurement of TT3 by immunoassay reliable at low concentrations? A comparison of the Roche Cobas 6000 vs. LC-MSMS.

Authors:  Likhona Siphe Masika; Zhen Zhao; Steven John Soldin
Journal:  Clin Biochem       Date:  2016-02-12       Impact factor: 3.281

2.  Longitudinal analysis reveals early-pregnancy associations between perfluoroalkyl sulfonates and thyroid hormone status in a Canadian prospective birth cohort.

Authors:  Anthony J F Reardon; Elham Khodayari Moez; Irina Dinu; Susan Goruk; Catherine J Field; David W Kinniburgh; Amy M MacDonald; Jonathan W Martin
Journal:  Environ Int       Date:  2019-05-28       Impact factor: 9.621

3.  Is there enough evidence of poor fetal growth to merit narrowing free T4 reference ranges during pregnancy?

Authors:  Tuija Männistö
Journal:  J Clin Endocrinol Metab       Date:  2013-01       Impact factor: 5.958

4.  Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease.

Authors:  Alice Accorroni; Filippo Sean Giorgi; Riccardo Donzelli; Leonardo Lorenzini; Concetta Prontera; Alessandro Saba; Andrea Vergallo; Gloria Tognoni; Gabriele Siciliano; Filippo Baldacci; Ubaldo Bonuccelli; Aldo Clerico; Riccardo Zucchi
Journal:  Endocrine       Date:  2016-02-22       Impact factor: 3.633

Review 5.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

6.  Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography.

Authors:  Xiwei Zheng; Maria Podariu; Ryan Matsuda; David S Hage
Journal:  Anal Bioanal Chem       Date:  2015-10-13       Impact factor: 4.142

7.  Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin.

Authors:  Xiwei Zheng; Ryan Matsuda; David S Hage
Journal:  J Chromatogr A       Date:  2014-10-31       Impact factor: 4.759

8.  Phenols and parabens in relation to reproductive and thyroid hormones in pregnant women.

Authors:  Amira M Aker; Deborah J Watkins; Lauren E Johns; Kelly K Ferguson; Offie P Soldin; Liza V Anzalota Del Toro; Akram N Alshawabkeh; José F Cordero; John D Meeker
Journal:  Environ Res       Date:  2016-07-21       Impact factor: 6.498

Review 9.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

10.  Effect of Hypothyroidism and Hyperthyroidism on Tissue Thyroid Hormone Concentrations in Rat.

Authors:  Riccardo Donzelli; Daria Colligiani; Claudia Kusmic; Martina Sabatini; Leonardo Lorenzini; Alice Accorroni; Monica Nannipieri; Alessandro Saba; Giorgio Iervasi; Riccardo Zucchi
Journal:  Eur Thyroid J       Date:  2016-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.